Loading clinical trials...
Loading clinical trials...
A Pilot Randomized Controlled Trial of Adding Enfuvirtide to Standard Combination Antiretroviral Therapy in HIV-infected Individuals With Full Virologic Suppression to Further Suppress Proviral HIV DNA
Conditions
Interventions
enfuvirtide
Locations
1
Canada
Maple Leaf Medical Clinic
Toronto, Ontario, Canada
Start Date
February 1, 2006
Primary Completion Date
July 1, 2007
Completion Date
January 1, 2010
Last Updated
June 5, 2012
NCT07055451
NCT05136703
NCT05668026
NCT04174755
NCT06691321
NCT06631365
Lead Sponsor
Canadian Immunodeficiency Research Collaborative
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions